Quince Therapeutics, Inc.
Investor Relations
Berichtstermine
Investor-Relations-Überblick zu Quince Therapeutics, Inc. (QNCX): Berichtstermine, Gewinn-Überraschungen, Earnings-Call-Mitschriften und aktuelle Meldungen. Der nächste Bericht ist für den 11.11.2026 angesetzt.
EPS-Schätzung geschlagen
Earnings-Call-Mitschriften
Noch keine Mitschriften vorhanden — sie erscheinen hier nach dem nächsten Earnings Call automatisch.
Nachrichten zur Aktie
- 19.10.2026 IRulya Therapeutics Inc. (QNCX): Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Öffnen ↗
- 09.10.2026 Quince Therapeutics, Inc. (QNCX): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Regulation FD Disclosure; Other Events; Financial Statements and Exhibits · sec.gov Öffnen ↗
- 06.10.2026 Quince Therapeutics, Inc. (QNCX): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits · sec.gov Öffnen ↗
- 02.10.2026 Quince Therapeutics, Inc. (QNCX): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers · sec.gov Öffnen ↗
- 14.09.2026 Quince Therapeutics, Inc. (QNCX): Completion of Acquisition or Disposition of Assets; Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Financial Statements and Exhibits · sec.gov Öffnen ↗
- 04.09.2026 Quince Therapeutics, Inc. (QNCX): Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing · sec.gov Öffnen ↗
- 27.08.2026 Quince Therapeutics, Inc. (QNCX): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers · sec.gov Öffnen ↗
- 17.08.2026 Quince Therapeutics, Inc. (QNCX): Other Events; Financial Statements and Exhibits · sec.gov Öffnen ↗
- 14.08.2026 Quince Therapeutics, Inc. (QNCX): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Öffnen ↗
- 31.07.2026 Quince Therapeutics, Inc. (QNCX): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers · sec.gov Öffnen ↗
Automatisch zugeordnete Agentur- und Portalmeldungen; externe Links öffnen die Originalquelle.
Datenstand: 3. November 2026 · Quelle: Fundamentaldaten & SEC-Berichte (Geschäfts- und Quartalsberichte, 10-K/10-Q) · Mitschriften: Transkript-Archiv
Hinweis: reine Faktenanalyse, keine Anlageberatung und keine Aufforderung zum Kauf oder Verkauf. Angaben ohne Gewähr.